MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2490
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1 ; volume:13 ; number:1 ; day:28 ; month:1 ; year:2013 ; pages:1-8 ; date:12.2013
BMC urology ; 13, Heft 1 (28.1.2013), 1-8, 12.2013
- Urheber
-
Olsson, Hans
- Beteiligte Personen und Organisationen
-
Hultman, Per
Rosell, Johan
Söderkvist, Peter
Jahnson, Staffan
SpringerLink (Online service)
- DOI
-
10.1186/1471-2490-13-5
- URN
-
urn:nbn:de:1111-2016071625008
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Olsson, Hans
- Hultman, Per
- Rosell, Johan
- Söderkvist, Peter
- Jahnson, Staffan
- SpringerLink (Online service)
Ähnliche Objekte (12)
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
Evolution of the p53-MDM2 pathway
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk
Small-Molecule Inhibitors of p53-MDM2 interactions
Serumantikörper gegen die Proteine p53, mdm2 und p21-waf1 und Nachweis der Proteine p53 und mdm2 in menschlichen Tumorgeweben
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
NAT 10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2
Mad1 destabilizes p53 by preventing PML from sequestering MDM2
Stress-specific response of the p53-Mdm2 feedback loop
Engineering a synthetic p53-Mdm2 network in budding yeast
Explaining oscillations and variability in the p53-Mdm2 system
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
Evolution of the p53-MDM2 pathway
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk
Small-Molecule Inhibitors of p53-MDM2 interactions
Serumantikörper gegen die Proteine p53, mdm2 und p21-waf1 und Nachweis der Proteine p53 und mdm2 in menschlichen Tumorgeweben
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
NAT 10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2
Mad1 destabilizes p53 by preventing PML from sequestering MDM2
Stress-specific response of the p53-Mdm2 feedback loop
Engineering a synthetic p53-Mdm2 network in budding yeast
Explaining oscillations and variability in the p53-Mdm2 system
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
Evolution of the p53-MDM2 pathway
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk
Small-Molecule Inhibitors of p53-MDM2 interactions
Serumantikörper gegen die Proteine p53, mdm2 und p21-waf1 und Nachweis der Proteine p53 und mdm2 in menschlichen Tumorgeweben
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
NAT 10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2
Mad1 destabilizes p53 by preventing PML from sequestering MDM2
Stress-specific response of the p53-Mdm2 feedback loop
Engineering a synthetic p53-Mdm2 network in budding yeast